Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability

Kurt, Mevlut; Oztas, Erkin; Kuran, Sedef; Onal, Ibrahim; KEKİLLİ, MURAT; HAZNEDAROĞLU, İBRAHİM

doi:10.1016/j.ajem.2008.09.003

Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability

Atıf İçin Kopyala

Kurt M., Oztas E., Kuran S., Onal I. K., KEKİLLİ M., HAZNEDAROĞLU İ. C.

AMERICAN JOURNAL OF EMERGENCY MEDICINE, cilt.27, sa.5, 2009 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 27 Sayı: 5
Basım Tarihi: 2009
Doi Numarası: 10.1016/j.ajem.2008.09.003
Dergi Adı: AMERICAN JOURNAL OF EMERGENCY MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Gazi Üniversitesi Adresli: Hayır

Özet

Ankaferd Blood Stopper (ABS) (Ankaferd Health Products Ltd., Istanbul, Turkey) is a standardized unique combined medicinal plant extract, which has been approved in the management of postsurgery dental bleeding and external hemorrhage in Turkey [1]. ABS induces a very rapid formation (<1 second) of a specific hemostatic protein network within vital erythroid aggregation in the injured vascular area [1]. The data on the efficacy of ABS in gastrointestinal (GI) system bleeding is limited to case reports only [2-4]. Here, we present a patient with a severe GI mucosal bleeding and nasal hemorrhage leading to hemodynamic instability, which was successfully controlled via the topical application of high-dose ABS.